Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Journal of Hematology & Oncology
|
May 15, 2009
Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome
Azra Raza, Naomi Galili, Natalie Callander, et al.
Journal of Medicinal Chemistry
|
September 17, 2004
Novel cyclooxygenase-1 inhibitors discovered using affinity fingerprints
Nancy Hsu, Danying Cai, Komath Damodaran, et al.
The Journal of Infectious Diseases
|
May 9, 2017
Crimean-Congo Hemorrhagic Fever in Humanized Mice Reveals Glial Cells as Primary Targets of Neurological Infection
Jessica R Spengler, M Kelly Keating, Anita K McElroy, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 27, 2010
Randomized phase III study of canfosfamide in combination with pegylated liposomal doxorubicin compared with pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer
Ignace Vergote, Neil J Finkler, James B Hall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 10, 2003
Phase I study of TLK286 (glutathione S-transferase P1-1 activated glutathione analogue) in advanced refractory solid malignancies
Lee S Rosen, Joseph Brown, Bernadette Laxa, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
May 23, 2023
Simultaneous evaluation of treatment efficacy and toxicity for bispecific T-cell engager therapeutics in a humanized mouse model
Jiwon Yang, Jing Jiao, Kyle M Draheim, et al.
Journal of Medicinal Chemistry
|
September 16, 2008
Design, synthesis, and structure-activity relationships of novel insulin receptor tyrosine kinase activators
Robert T Lum, Mingshan Cheng, Cristina P Cristobal, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 18, 2017
Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy
Minan Wang, Li-Chin Yao, Mingshan Cheng, et al.
Molecular Cancer Therapeutics
|
February 28, 2018
Antitumor Activity of Osimertinib, an Irreversible Mutant-Selective EGFR Tyrosine Kinase Inhibitor, in NSCLC Harboring EGFR Exon 20 Insertions
Nicolas Floc'h, Matthew J Martin, Jonathan W Riess, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 25, 2009
Phase 1-2a multicenter dose-ranging study of canfosfamide in combination with carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancer
Lecia V Sequist, Panos M Fidias, Jennifer S Temel, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Journal of Hematology & Oncology
|
May 15, 2009
Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome
Azra Raza, Naomi Galili, Natalie Callander, et al.
Journal of Medicinal Chemistry
|
September 17, 2004
Novel cyclooxygenase-1 inhibitors discovered using affinity fingerprints
Nancy Hsu, Danying Cai, Komath Damodaran, et al.
The Journal of Infectious Diseases
|
May 9, 2017
Crimean-Congo Hemorrhagic Fever in Humanized Mice Reveals Glial Cells as Primary Targets of Neurological Infection
Jessica R Spengler, M Kelly Keating, Anita K McElroy, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 27, 2010
Randomized phase III study of canfosfamide in combination with pegylated liposomal doxorubicin compared with pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer
Ignace Vergote, Neil J Finkler, James B Hall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 10, 2003
Phase I study of TLK286 (glutathione S-transferase P1-1 activated glutathione analogue) in advanced refractory solid malignancies
Lee S Rosen, Joseph Brown, Bernadette Laxa, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
May 23, 2023
Simultaneous evaluation of treatment efficacy and toxicity for bispecific T-cell engager therapeutics in a humanized mouse model
Jiwon Yang, Jing Jiao, Kyle M Draheim, et al.
Journal of Medicinal Chemistry
|
September 16, 2008
Design, synthesis, and structure-activity relationships of novel insulin receptor tyrosine kinase activators
Robert T Lum, Mingshan Cheng, Cristina P Cristobal, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 18, 2017
Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy
Minan Wang, Li-Chin Yao, Mingshan Cheng, et al.
Molecular Cancer Therapeutics
|
February 28, 2018
Antitumor Activity of Osimertinib, an Irreversible Mutant-Selective EGFR Tyrosine Kinase Inhibitor, in NSCLC Harboring EGFR Exon 20 Insertions
Nicolas Floc'h, Matthew J Martin, Jonathan W Riess, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 25, 2009
Phase 1-2a multicenter dose-ranging study of canfosfamide in combination with carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancer
Lecia V Sequist, Panos M Fidias, Jennifer S Temel, et al.
Page
of 8